Blueprint Medicines Corp Annual Shareholders Meeting Transcript
Good afternoon, ladies and gentlemen, and welcome to the Blueprint Medicines Annual Shareholder Meeting. At this time, the meeting will begin. It is now my pleasure to turn the floor over to your host, Jeffrey Albers. Sir, the floor is yours.
Thank you, and good morning, ladies and gentlemen. It's a pleasure to welcome you to our 2020 annual meeting of stockholders, which is being held virtually this year via the Internet. I'm Jeff Albers, President and Chief Executive Officer of Blueprint Medicines, and I'll serve as Chair of this meeting. Chris Frankenfield, our Vice President, Corporate Legal Affairs, will serve as Secretary Pro Tem and guide us through the proceedings today.
With that, I now call the meeting to order and will hand it over to Chris to conduct the formal business of the meeting.
Thanks, Jeff. The business before this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |